PTEN regulate angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells

Molecular and Cellular Biochemistry

Volumn 331, Issue 1-2, 2009, Pages 161-171

  Ma, Jiachi ^a   Sawai, Hirozumi ^a   Ochi, Nobuo ^a   Matsuo, Yoichi ^a   Xu, Donghui ^a   Yasuda, Akira ^a   Takahashi, Hiroki ^a   Wakasugi, Takehiro ^a   Takeyama, Hiromitsu ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Angiogenesis; Pancreatic cancer; PTEN; VEGF

Indexed keywords

MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL INTERFERING RNA; VASCULOTROPIN; CINNAMIC ACID DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, HUMAN; PROTEIN KINASE B; PTEN PROTEIN, HUMAN; SU 1498; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PROTEIN SECRETION; SIGNAL TRANSDUCTION; UPREGULATION; CELL FRACTIONATION; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PANCREAS TUMOR; TUMOR CELL LINE; UMBILICAL VEIN; VASCULARIZATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CINNAMATES; ENDOTHELIAL CELLS; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SUBCELLULAR FRACTIONS; TRANSFECTION; UMBILICAL VEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 74049134054     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-009-0154-x     Document Type: Article

References (37)

1. Tao J, Xiong J, Li T, Yang Z et al (2006) Correlation between protein expression of PTEN in human pancreatic cancer and the proliferation, infiltration, metastasis and prognosis. J Huazhong Univ Sci Technol Med Sci 26:444-447. doi:10.1007/s11596-006-0417-7
2. Hsu SC, Volpert OV, Steck PA, Mikkelsen T et al (1996) Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. Cancer Res 56:5684-5691
3. Stambolic V, Suzuki A (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95:29-39. doi:10.1016/S0092- 8674(00)81780-8 (Pubitemid 28458022)
4. Stambolic V, Tsao MS, Macpherson D, Suzuki A et al (2000) High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Res 60: 3605-3611
5. Liaw D, Marsh DJ, Li J, Dahia PL et al (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67. doi:10.1038/ng0597-64
6. Marsh DJ, Dahia PL, Zheng Z, Liaw D et al (1997) Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 16:333-334. doi:10.1038/ng0897-333
7. Chow JY, Quach KT, Cabrera BL, Cabral JA et al (2007) RAS/ ERK modulates TGFbeta-regulated PTEN expression in human pancreatic adenocarcinoma cells. Carcinogenesis 28:2321-2327. doi:10.1093/carcin/bgm159 (Pubitemid 350111590)
8. Cantley LC, Neel BG (1999) New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96:4240-4245. doi:10.1073/pnas.96.8.4240 (Pubitemid 29190320)
9. Dong JT, Sipe TW, Hyytinen ER, Li CL, Heise C et al (1998) PTEN/MMAC1 is infrequently mutated in pT2 and pT3 carcinomas of the prostate. Oncogene 17:1979-1982. doi:10.1038/sj.onc.1202119
10. Simpson L, Parsons R (2001) PTEN: life as a tumor suppressor. Exp Cell Res 264:29-41. doi:10.1006/excr.2000.5130 (Pubitemid 32989079)
11. Alvarez-Nunez F, Bussaglia E, Mauricio D, Ybarra J et al (2006) PTEN promoter methylation in sporadic thyroid carcinomas. Thyroid 16:17-23. doi:10.1089/thy.2006.16.17 (Pubitemid 43346499)
12. Mirmohammadsadegh A, Marini A, Nambiar S, Hassan M et al (2006) Epigenetic silencing of the PTEN gene in melanoma. Cancer Res 66:6546-6552. doi:10.1158/0008-5472.CAN-06-0384 (Pubitemid 44085609)
13. Marsit CJ, Zheng S, Aldape K, Hinds PW et al (2005) PTEN expression in non-small-cell lung cancer: evaluating its relation to tumor characteristics, allelic loss, and epigenetic alteration. Hum Pathol 36:768-776. doi:10.1016/j.humpath.2005.05.006 (Pubitemid 41112032)
14. Wiencke JK, Zheng S, Jelluma N, Tihan T et al (2007) Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma. Neuro-oncology 9:271-279. doi:10.1215/15228517-2007-003 (Pubitemid 47169659)
15. Aoki M, Schetter C, Himly M, Batista O et al (2000) The catalytic subunit of phosphoinositide 3-kinase: requirements for oncogenicity. J Biol Chem 275:6267-6275. doi:10.1074/jbc.275.9.6267 (Pubitemid 30129917)
16. Sakurada A, Suzuki A, Sato M, Yamakawa H et al (1997) Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary. Jpn J Cancer Res 88:1025-1028
17. Escriva M, Peiro S, Herranz N, Villagrasa P, Dave N et al (2008) Repression of PTEN phosphatase by Snail1 transcriptional factor during gamma radiation-induced apoptosis. Mol Cell Biol 28:1528-1540. doi:10.1128/MCB.02061- 07
18. Wang Q, Zhou Y, Wang X, Chung DH et al (2007) Regulation of PTEN expression in intestinal epithelial cells by c-Jun NH2-ter-minal kinase activation and nuclear factor-kappaB inhibition. Cancer Res 67:7773-7781. doi:10.1158/0008-5472.CAN-07-0187 (Pubitemid 47281371)
19. Jiang BH, Zheng JZ, Aoki M et al (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci USA 97:1749-1753. doi:10.1073/pnas.040560897 (Pubitemid 30118514)
20. Ferrara N (2000) Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res 55:15-35 (discussion 35-16)
21. Thakker GD, Hajjar DP, Muller WA et al (1999) The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J Biol Chem 274:10002-10007. doi:10.1074/jbc.274.15.10002 (Pubitemid 29180863)
22. Hamada K, Sasaki T, Koni PA, Natsui M et al (2005) The PTEN/ PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 19:2054-2065. doi:10.1101/gad.1308805 (Pubitemid 41247962)
23. Giri D, Ittmann M (1999) Inactivation of the PTEN tumor suppressor gene is associated with increased angiogenesis in clinically localized prostate carcinoma. Hum Pathol 30:419-424. doi:10.1016/S0046-8177(99)90117-X
24. Wen S, Stolarov J, Myers MP, Su JD et al (2001) PTEN controls tumor-induced angiogenesis. Proc Natl Acad Sci USA 98:4622-4627. doi:10.1073/pnas.081063798 (Pubitemid 32295026)
25. Tahir SA, Yang G, Goltsov AA et al (2008) Tumor cell-secreted caveolin-1 has proangiogenic activity in prostate cancer. Cancer Res 68:731-739. doi:10.1158/0008-5472.CAN-07-2668 (Pubitemid 351206749)
26. Chung BH, Kim CK (2008) Icariin stimulates angiogenesis by activating the MEK/ERK-and PI3K/Akt/eNOS-dependent signal pathway in human endothelial cells. Biochem Biophys Res Commun 376:404-408. doi:10.1016/j.bbrc.2008.09.001
27. Ferrara N, Chen H, Davis-Smyth T et al (1998) Vascular endo-thelial growth factor is essential for corpus luteum angiogenesis. Nat Med 4:336-340. doi:10.1038/nm0398-336 (Pubitemid 28144094)
28. Ma J, Sawai H, Matsuo Y, Ochi N et al (2008) IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells. J Surg Res. doi:10.1016/j.jss.2008.08.016
29. Dayanir V, Meyer RD, Lashkari K, Rahimi N (2001) Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biochem 276:17686-17692
30. Lee SJ, Kim NamkoongYM, Kim CK, Lee H et al (2006) Frac-talkine stimulates angiogenesis by activating the Raf-/MMK/ ERK-and PI3K/Akt/eNOS- dependent signal pathway. Am J Physiol Heart Circ Physiol 291:H2836-H2846. doi:10.1152/ajpheart.00113.2006 (Pubitemid 44904084)
31. Papapetropoulos A, Rudic RD, Sessa WC (1999) Molecular control of nitric oxide synthases in the cardiovascular system. Cardiovasc Res 43:509-520. doi:10.1016/S0008-6363(99)00161-3 (Pubitemid 29369250)
32. Dimmeler S, Dernbach E, Zeiher AM (2000) Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett 477:258-262. doi:10.1016/S0014-5793(00) 01657-4 (Pubitemid 30450177)
33. Gomez-Manzano C, Fueyo J, Jiang H, Glass TL et al (2003) Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis. Ann Neurol 53:109-117. doi:10.1002/ana.10396 (Pubitemid 36083835)
34. Koul D, Shen R, Garyali A, Ke LD et al (2002) MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. Int J Oncol 21:469-475
35. Huang J, Kzontos CD (2002) PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. J Biol Chem 277:10760-10766. doi:10.1074/jbc.M110219200 (Pubitemid 34952828)
36. Jiang BH, Liu LZ (2008) PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochim Biophys Acta 1784:150-158
37. Kontos CD, Stauffer TP, Yang WP, York JD et al (1998) Tyro-sine 1101 of Tie2 is the major site of association of p85 and is required for activation of phosphatidylinositol 3-kinase and Akt. Mol Cell Biol 18:4131-4140